Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus

被引:98
作者
Llorente, L [1 ]
RichaudPatin, Y [1 ]
Couderc, J [1 ]
AlarconSegovia, D [1 ]
RuizSoto, R [1 ]
AlcocerCastillejos, N [1 ]
AlcocerVarela, J [1 ]
Granados, J [1 ]
Bahena, S [1 ]
Galanaud, P [1 ]
Emilie, D [1 ]
机构
[1] INST PARIS SUD CYTOKINES,CLAMART,FRANCE
来源
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 08期
关键词
D O I
10.1002/art.1780400810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate interleukin-10 (IL-10) production in relatives of patients with systemic lupus erythematosus (SLE). Methods. Production of IL-10 was evaluated in 13 families in which several members had SLE, The constitutive IL-10 production in SLE patients (n = 16) was compared with that in healthy members of these multiplex families (n = 70), in 30 SLE patients who had no relatives with SLE, and in 46 healthy unrelated controls. Results. The level of IL-10 production did not differ between SLE patients who were members and those who were not members of multiplex families (mean +/- SEM 4,384 +/- 908 pg/ml and 4,709 +/- 560 pg/ml, respectively), but was higher in both groups than in healthy unrelated controls (515 +/- 88 pg/ml). The healthy members of the multiplex families constitutively produced large amounts of IL-10 (3,080 +/- 311 pg/ml; P < 0.001 compared with healthy unrelated controls). This high IL-10 production was independent of age and sex, and was similar in first- and second-degree relatives of SLE patients, The IL-10 was produced both by monocytes and by a subpopulation of B lymphocytes in SLE patients and in their relatives. Conclusion. The dysregulation of IL-10 production previously identified in SLE patients is also present in healthy members of families with several cases of SLE, and it may contribute to the immunologic abnormalities affecting relatives of SLE patients.
引用
收藏
页码:1429 / 1435
页数:7
相关论文
共 35 条
[11]   BIOLOGICAL PROPERTIES OF INTERLEUKIN-10 [J].
HOWARD, M ;
OGARRA, A .
IMMUNOLOGY TODAY, 1992, 13 (06) :198-200
[12]   POPULATION AND FAMILY STUDIES OF 3 DISEASE-RELATED POLYMORPHIC GENES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
HUANG, DF ;
SIMINOVITCH, KA ;
LIU, XY ;
OLEE, T ;
OLSEN, NJ ;
BERRY, C ;
CARSON, DA ;
CHEN, PP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1766-1772
[13]   CONTINUOUS ANTI-INTERLEUKIN 10 ANTIBODY ADMINISTRATION DEPLETES MICE OF LY-1 B-CELLS BUT NOT CONVENTIONAL B-CELLS [J].
ISHIDA, H ;
HASTINGS, R ;
KEARNEY, J ;
HOWARD, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1213-1220
[14]   CONTINUOUS ADMINISTRATION OF ANTI-INTERLEUKIN-10 ANTIBODIES DELAYS ONSET OF AUTOIMMUNITY IN NZB/W F1-MICE [J].
ISHIDA, H ;
MUCHAMUEL, T ;
SAKAGUCHI, S ;
ANDRADE, S ;
MENON, S ;
HOWARD, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :305-310
[15]   SYSTEMIC AUTOIMMUNE-DISEASE ARISES FROM POLYCLONAL B-CELL ACTIVATION [J].
KLINMAN, DM ;
STEINBERG, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1755-1760
[16]   LUPUS SUSCEPTIBILITY LOCI IN NEW-ZEALAND MICE [J].
KONO, DH ;
BURLINGAME, RW ;
OWENS, DG ;
KURAMOCHI, A ;
BALDERAS, RS ;
BALOMENOS, D ;
THEOFILOPOULOS, AN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10168-10172
[17]   Systemic lupus erythematosus [J].
Kotzin, BL .
CELL, 1996, 85 (03) :303-306
[18]  
KUMAR A, 1991, ARTHRITIS RHEUM, V34, P1553
[19]  
LINKERISRAELI M, 1983, J IMMUNOL, V130, P2651
[20]  
LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421